Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice

Todd R. Harris, Ahmed Bettaieb, Sean Kodani, Hua Dong, Richard Myers, Nipavan Chiamvimonvat, Fawaz Haj, Bruce D. Hammock

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Liver fibrosis is a pathological condition in which chronic inflammation and changes to the extracellular matrix lead to alterations in hepatic tissue architecture and functional degradation of the liver. Inhibitors of the enzyme soluble epoxide hydrolase (sEH) reduce fibrosis in the heart, pancreas and kidney in several disease models. In this study, we assess the effect of sEH inhibition on the development of fibrosis in a carbon tetrachloride (CCl<inf>4</inf>)-induced mouse model by monitoring changes in the inflammatory response, matrix remolding and endoplasmic reticulum stress. The sEH inhibitor 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) was administered in drinking water. Collagen deposition in the liver was increased five-fold in the CCl<inf>4</inf>-treated group, and this was returned to control levels by TPPU treatment. Hepatic expression of Col1a2 and 3a1 mRNA was increased over fifteen-fold in the CCl<inf>4</inf>-treated group relative to the Control group, and this increase was reduced by 50% by TPPU treatment. Endoplasmic reticulum (ER) stress observed in the livers of CCl<inf>4</inf>-treated animals was attenuated by TPPU treatment. In order to support the hypothesis that TPPU is acting to reduce the hepatic fibrosis and ER stress through its action as a sEH inhibitor we used a second sEH inhibitor, trans-4-{4-[3-(4-trifluoromethoxy-phenyl)-ureido]-cyclohexyloxy}-benzoic acid (t-TUCB), and sEH null mice. Taken together, these data indicate that the sEH may play an important role in the development of hepatic fibrosis induced by CCl<inf>4</inf>, presumably by reducing endogenous fatty acid epoxide chemical mediators acting to reduce ER stress.

Original languageEnglish (US)
Pages (from-to)102-111
Number of pages10
JournalToxicology and Applied Pharmacology
Volume286
Issue number2
DOIs
StatePublished - Jul 5 2015

Fingerprint

Epoxide Hydrolases
Endoplasmic Reticulum Stress
Carbon Tetrachloride
Fibrosis
Liver
Epoxy Compounds
Level control
Enzyme Inhibitors
Drinking Water
Liver Cirrhosis
Extracellular Matrix
Urea
Pancreas
Animals
Collagen
Fatty Acids
Tissue
Inflammation
Kidney
Degradation

Keywords

  • Carbon tetrachloride
  • Endoplasmic reticulum stress
  • Fibrosis
  • Soluble epoxide hydrolase

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice. / Harris, Todd R.; Bettaieb, Ahmed; Kodani, Sean; Dong, Hua; Myers, Richard; Chiamvimonvat, Nipavan; Haj, Fawaz; Hammock, Bruce D.

In: Toxicology and Applied Pharmacology, Vol. 286, No. 2, 05.07.2015, p. 102-111.

Research output: Contribution to journalArticle

Harris, Todd R. ; Bettaieb, Ahmed ; Kodani, Sean ; Dong, Hua ; Myers, Richard ; Chiamvimonvat, Nipavan ; Haj, Fawaz ; Hammock, Bruce D. / Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice. In: Toxicology and Applied Pharmacology. 2015 ; Vol. 286, No. 2. pp. 102-111.
@article{bf32f9ab8e2443f88a198b25fbe7dd75,
title = "Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice",
abstract = "Liver fibrosis is a pathological condition in which chronic inflammation and changes to the extracellular matrix lead to alterations in hepatic tissue architecture and functional degradation of the liver. Inhibitors of the enzyme soluble epoxide hydrolase (sEH) reduce fibrosis in the heart, pancreas and kidney in several disease models. In this study, we assess the effect of sEH inhibition on the development of fibrosis in a carbon tetrachloride (CCl4)-induced mouse model by monitoring changes in the inflammatory response, matrix remolding and endoplasmic reticulum stress. The sEH inhibitor 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) was administered in drinking water. Collagen deposition in the liver was increased five-fold in the CCl4-treated group, and this was returned to control levels by TPPU treatment. Hepatic expression of Col1a2 and 3a1 mRNA was increased over fifteen-fold in the CCl4-treated group relative to the Control group, and this increase was reduced by 50{\%} by TPPU treatment. Endoplasmic reticulum (ER) stress observed in the livers of CCl4-treated animals was attenuated by TPPU treatment. In order to support the hypothesis that TPPU is acting to reduce the hepatic fibrosis and ER stress through its action as a sEH inhibitor we used a second sEH inhibitor, trans-4-{4-[3-(4-trifluoromethoxy-phenyl)-ureido]-cyclohexyloxy}-benzoic acid (t-TUCB), and sEH null mice. Taken together, these data indicate that the sEH may play an important role in the development of hepatic fibrosis induced by CCl4, presumably by reducing endogenous fatty acid epoxide chemical mediators acting to reduce ER stress.",
keywords = "Carbon tetrachloride, Endoplasmic reticulum stress, Fibrosis, Soluble epoxide hydrolase",
author = "Harris, {Todd R.} and Ahmed Bettaieb and Sean Kodani and Hua Dong and Richard Myers and Nipavan Chiamvimonvat and Fawaz Haj and Hammock, {Bruce D.}",
year = "2015",
month = "7",
day = "5",
doi = "10.1016/j.taap.2015.03.022",
language = "English (US)",
volume = "286",
pages = "102--111",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice

AU - Harris, Todd R.

AU - Bettaieb, Ahmed

AU - Kodani, Sean

AU - Dong, Hua

AU - Myers, Richard

AU - Chiamvimonvat, Nipavan

AU - Haj, Fawaz

AU - Hammock, Bruce D.

PY - 2015/7/5

Y1 - 2015/7/5

N2 - Liver fibrosis is a pathological condition in which chronic inflammation and changes to the extracellular matrix lead to alterations in hepatic tissue architecture and functional degradation of the liver. Inhibitors of the enzyme soluble epoxide hydrolase (sEH) reduce fibrosis in the heart, pancreas and kidney in several disease models. In this study, we assess the effect of sEH inhibition on the development of fibrosis in a carbon tetrachloride (CCl4)-induced mouse model by monitoring changes in the inflammatory response, matrix remolding and endoplasmic reticulum stress. The sEH inhibitor 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) was administered in drinking water. Collagen deposition in the liver was increased five-fold in the CCl4-treated group, and this was returned to control levels by TPPU treatment. Hepatic expression of Col1a2 and 3a1 mRNA was increased over fifteen-fold in the CCl4-treated group relative to the Control group, and this increase was reduced by 50% by TPPU treatment. Endoplasmic reticulum (ER) stress observed in the livers of CCl4-treated animals was attenuated by TPPU treatment. In order to support the hypothesis that TPPU is acting to reduce the hepatic fibrosis and ER stress through its action as a sEH inhibitor we used a second sEH inhibitor, trans-4-{4-[3-(4-trifluoromethoxy-phenyl)-ureido]-cyclohexyloxy}-benzoic acid (t-TUCB), and sEH null mice. Taken together, these data indicate that the sEH may play an important role in the development of hepatic fibrosis induced by CCl4, presumably by reducing endogenous fatty acid epoxide chemical mediators acting to reduce ER stress.

AB - Liver fibrosis is a pathological condition in which chronic inflammation and changes to the extracellular matrix lead to alterations in hepatic tissue architecture and functional degradation of the liver. Inhibitors of the enzyme soluble epoxide hydrolase (sEH) reduce fibrosis in the heart, pancreas and kidney in several disease models. In this study, we assess the effect of sEH inhibition on the development of fibrosis in a carbon tetrachloride (CCl4)-induced mouse model by monitoring changes in the inflammatory response, matrix remolding and endoplasmic reticulum stress. The sEH inhibitor 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) was administered in drinking water. Collagen deposition in the liver was increased five-fold in the CCl4-treated group, and this was returned to control levels by TPPU treatment. Hepatic expression of Col1a2 and 3a1 mRNA was increased over fifteen-fold in the CCl4-treated group relative to the Control group, and this increase was reduced by 50% by TPPU treatment. Endoplasmic reticulum (ER) stress observed in the livers of CCl4-treated animals was attenuated by TPPU treatment. In order to support the hypothesis that TPPU is acting to reduce the hepatic fibrosis and ER stress through its action as a sEH inhibitor we used a second sEH inhibitor, trans-4-{4-[3-(4-trifluoromethoxy-phenyl)-ureido]-cyclohexyloxy}-benzoic acid (t-TUCB), and sEH null mice. Taken together, these data indicate that the sEH may play an important role in the development of hepatic fibrosis induced by CCl4, presumably by reducing endogenous fatty acid epoxide chemical mediators acting to reduce ER stress.

KW - Carbon tetrachloride

KW - Endoplasmic reticulum stress

KW - Fibrosis

KW - Soluble epoxide hydrolase

UR - http://www.scopus.com/inward/record.url?scp=84930274047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930274047&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2015.03.022

DO - 10.1016/j.taap.2015.03.022

M3 - Article

C2 - 25827057

AN - SCOPUS:84930274047

VL - 286

SP - 102

EP - 111

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 2

ER -